基于网络药理学快筛降尿酸药食同源成分

李昕 ,  马永丽 ,  杨国栋 ,  单晓宇 ,  翟一凡 ,  张杰

齐鲁工业大学学报 ›› 2026, Vol. 40 ›› Issue (5) : 60 -71.

PDF (19496KB)
齐鲁工业大学学报 ›› 2026, Vol. 40 ›› Issue (5) : 60 -71. DOI: 10.16442/j.cnki.qlgydxxb.2026.05.007
食品与生物工程

基于网络药理学快筛降尿酸药食同源成分

作者信息 +

Rapid screening of uric acid-lowering drugs with medicine and food homology properties based on network pharmacology

Author information +
文章历史 +
PDF (19963K)

摘要

基于网络药理学和分子对接技术结合 CNKI 数据库自 106 种药食同源物质中快速筛选具有降尿酸功能成分,为降尿酸药食同源产品开发提供理论依据。以 106 种药食同源物质为研究对象,使用 TCMSP、Uniprot 等平台对药食同源物质活性成分及靶点进行检索,结合自 GeneCards 和 OMIM 收集到的高尿酸血症相关靶点,使用 Venny2.1 构建药食同源物质与高尿酸血症靶点交集图,确定目标物质。以 CNKI 数据库为基础,利用文献计量学方法对降尿酸药食同源物质的实验研究结果进行分析,针对性筛选出排名前 5 的物质作为高频研究中药。通过数据库检索获取高频中药中化合物作用靶点以及高尿酸血症靶点,利用 Cytoscape3.10.0 建立“成分-疾病-靶点”网络,借助 GO 分析和 KEGG 通路分析,并将核心靶点与关键成分进行分子对接验证。筛选出黄芪、白果、甘草、桑叶和栀子 5 种高频药物,共确定 88 个能够作用于高尿酸血症的核心靶点,主要活性成分包括槲皮素、山柰酚、芒柄花素等,核心靶点为 TP53、TNF、IL6 等。5 种中药治疗高尿酸血症的作用机制主要涉及通过参与脂多糖反应、细胞因子活性等生物过程并作用于脂质与动脉粥样硬化、AGE-RAGE、TNF 等信号通路而实现。分子对接结果表明,核心靶点与核心活性成分具有较好的结合活性,其中靶点 PPARG 与 β-谷甾醇呈现出最高的亲和力为-9.7kcal/ mol。研究筛选了具有较好降尿酸功能的 5 种药食同源成分,并预测其通过调控多靶点、多通路发挥改善高尿酸血症的作用,为药食同源物质治疗高尿酸血症的分子研究和产品开发提供了科学依据。

Abstract

To rapidly screen for components with uric acid-lowering functions from 106 medicine and food homology substances using a combination of network pharmacology and molecular docking technology in conjunction with the CNKI database, thereby providing a theoretical basis for the development of uric acid-lowering medicine and food homology products. Taking 106 medicine and food homology substances as the research objects, we used platforms such as TCMS P and Uniprot to search for the active components and targets of these substances. Combining this with targets related to hyperuricemia collected from GeneCards and OMIM, we used Venny2. 1 to construct an intersection diagram between the medicine and food homology substances and hyperuricemia targets, thereby identifying the target substances. Based on the CNKI database, we analysed the experimental research results of uric acid-lowering medicine and food homology substances using bibliometric methods, and screened the top 5 substances as high-frequency research traditional Chinese medicines. Through database searches, we obtained the compound action targets and hyperuricemia targets of high-frequency traditional Chinese medicines. Using Cytoscape 3.10.0, we established a “ component-disease-target” network, and through GO analysis and KEGG pathway analysis, we verified the core targets and key components through molecular docking. Five high-frequency drugs were screened out, including Astragalus, Ginkgo biloba, Licorice, Mulberry leaf, and Gardenia, with a total of 88 core targets identified that can act on hyperuricemia. The main active components include quercetin, kaempferol, and mangiferin, with core targets including TP53, TNF, IL6, etc. The mechanisms of action of the five traditional Chinese medicines in treating hyperuricemia primarily involve participating in biological processes such as lipopolysaccharide responses and cytokine activity, and acting on lipid and atherosclerosis, AGE-RAGE, TNF, and other signalling pathways. Molecular docking results indicate that core targets and core active components exhibit good binding activity, with the target PPARG exhibiting the highest affinity of -9. 7 kcal/ mol with β-sitosterol. This study screened five medicine and food homology components with good uric acid-lowering functions and predicted their mechanisms of action in improving hyperuricemia through multi-target, multi-pathway regulation, providing scientific basis for molecular research and product development of medicine and food homology substances for the treatment of hyperuricemia.

关键词

药食同源 / 高尿酸血症 / 网络药理学 / 分子对接 / 作用机制

Key words

medicine and food homology / hyperuricemia / network pharmacology / molecular docking / mechanism

引用本文

引用格式 ▾
李昕,马永丽,杨国栋,单晓宇,翟一凡,张杰. 基于网络药理学快筛降尿酸药食同源成分[J]. 齐鲁工业大学学报, 2026, 40(5): 60-71 DOI:10.16442/j.cnki.qlgydxxb.2026.05.007

登录浏览全文

4963

注册一个新账户 忘记密码

参考文献

[1]

张超, 常岭迪, 冯伟, 等. 高尿酸血症发病机制与治疗策略的研究进展[J]. 空军军医大学学报, 2024, 45(10): 1184-1190.

[2]

Kuo Changfu, Grainge MJ, Zhang Weiya, et al. Global epidemiology of gout: Prevalence, incidence and risk factors[J]. Nature Reviews Rheumatology, 2015, 11(11): 649-662.

[3]

方宁远, 吕力为, 吕晓希, 等. 中国高尿酸血症相关疾病诊疗多学科专家共识(2023 年版)[J]. 中国实用内科杂志, 2023, 43(6): 461-480.

[4]

Hou Yan, Jiang Jianguo. Origin and concept of medicine food homology and its application in modern functional foods[J]. Food & Function, 2013, 4(12): 1727-1741.

[5]

吴丹, 马科, 闫靖楠, 等. “药食同源” 中药在肺癌中的应用及其网络药理学研究[J]. 宁夏医科大学学报, 2024, 46(5): 470-479.

[6]

李凯文, 曹慧雅, 刘梦扬, 等. 药食两用中药防治高尿酸血症的研究进展[J]. 沈阳药科大学学报, 2023, 40(8): 1124-1132.

[7]

林娜, 王筑山, 廖兴江, 等. 药食两用中药在痛风防治中的研究进展[J]. 食品与药品, 2022, 24(2): 172-177.

[8]

Zhang Wenwen, Cui Yifang, Zhang Jiayu. Multimetabolomics-based analysis of application of Astragalus membranaceus in the treatment of hyperuricemia[J]. Frontiers in Pharmacology, 2022, 13: 948939.

[9]

Xia Hongjuan, He Wenjiang, Lv Chenghao, et al. The inhibitory effect of Astragalus flavone extract on hyperuricemia and its underlying molecular mechanism by targeting JNK/ AP-1/ NLRP3/ IL-1β signaling pathway[J]. Phytomedicine, 2025, 140: 156622.

[10]

Zhang Cen, Wang Rui, Zhang Guowen, et al. Mechanistic insights into the inhibition of quercetin on xanthine oxidase[J]. International Journal of Biological Macromolecules, 2018, 112: 405-412.

[11]

Dalbeth N, Gosling AL, Gaffo A, et al. Gout[J]. The Lancet, 2021, 397(10287): 1843-1855.

[12]

Hopkins AL. Network pharmacology: The next paradigm in drug discovery[J]. Nature Chemical Biology, 2008, 4(11): 682-690. DOI: 10.1038/nchembio.118.

[13]

刘艾林, 杜冠华. 网络药理学:药物发现的新思想[J]. 药学学报, 2010, 45(12): 1472-1477.

[14]

Gray JJ, Moughon S, Wang Chu, et al. Protein-protein docking with simultaneous optimization of rigid-body displacement and side-chain conformations[J]. Journal of Molecular Biology, 2003, 331(1): 281-299.

[15]

Ru Jinlong, Li Peng, Wang Jinan, et al. TCMS P: A database of systems pharmacology for drug discovery from herbal medicines[J]. Journal of Cheminformatics, 2014, 6(1): 13.

[16]

Liu Hui, Wang Jinan, Zhou Wei, et al. Systems approaches and polypharmacology for drug discovery from herbal medicines: An example using licorice[J]. Journal of Ethnopharmacology, 2013, 146(3): 773-793.

[17]

Consortium TU. UniProt: The universal protein knowledge base[J]. Nucleic Acids Research, 2017, 45(D1): D158-D169.

[18]

Stelzer G, Rosen N, Plaschkes I, et al. The GeneCards suite: From gene data mining to disease genome sequence analyses[J]. Current Protocols in Bioinformatics, 2016, 54: 1.30.1-1.30.33.

[19]

Lee-Barber J, Kulo V, Lehmann H, et al. Bioinformatics for medical students: A 5-year experience using OMIM® in medical student education[J]. Genetics in Medicine, 2019, 21(2): 493-497.

[20]

Szklarczyk D, Nastou K, Koutrouli M, et al. The STRING database in 2025: Protein networks with directionality of regulation[J]. Nucleic Acids Research, 2025, 53(D1): D730-D737.

[21]

Minoru K, Miho F, Yoko S, et al. KEGG: integrating viruses and cellular organisms[J]. Nucleic Acids Research, 2021, 49(D1): D545-D551.

[22]

Liu Yang, Yang Xiaocong, Gan Jianhong, et al. CB-Dock2: Improved protein-ligand blind docking by integrating cavity detection, docking and homologous template fitting[J]. Nucleic Acids Research, 2022, 50(W1): W159-W164.

[23]

Vareldzis R, Perez A, Reisin E. Hyperuricemia: An intriguing connection to metabolic syndrome, diabetes, kidney disease, and hypertension[J]. Current Hypertension Reports, 2024, 26(6): 237-245.

[24]

徐楚, 田晔. 加味四妙勇安汤调节肠道菌群治疗高尿酸血症的网络药理学分析[J]. 中国微生态学杂志, 2024, 36(11): 1267-1275.

[25]

陈丕平, 唐霞珠, 王路宁, 等. 银杏叶提取物对慢性高尿酸血症肾病的疗效[J]. 中国中西医结合肾病杂志, 2001, 2(11): 644-645.

[26]

Zhou Hongyan, Song Xinyu, Tian Yingying, et al. Isoliquiritigenin promotes the repair of high uric acid-induced vascular injuries[J]. Smart Medicine, 2025, 4(2): e70000.

[27]

Meng Qinghai, Qi Xu, Chao Ying, et al. IRS1/ PI3K/ AKT pathway signal involved in the regulation of glycolipid metabolic abnormalities by Mulberry(Morus alba L.) leaf extracts in 3T3-L1 adipocytes[J]. Chinese Medicine, 2020, 15(1): 1.

[28]

Chen Liping, Li Maoxing, Yang Zhiqiang, et al. Gardenia jasminoides Ellis: Ethnopharmacology, phytochemistry, and pharmacological and industrial applications of an important traditional Chinese medicine[J]. Journal of Ethnopharmacology, 2020, 257: 112829.

[29]

Yang Dengyu, Wang Tiancheng, Long Miao, et al. Quercetin: Its main pharmacological activity and potential application in clinical medicine[J]. Oxidative Medicine and Cellular Longevity, 2020, 2020(3): 1-13.

[30]

Imran M, Salehi B, Sharifi-Rad J, et al. Kaempferol: A key emphasis to its anticancer potential[J]. Molecules, 2019, 24(12): 2277.

[31]

姚芳芳, 张锐, 傅瑞娟, 等. 槲皮素对高尿酸血症大鼠黄嘌呤氧化酶和腺苷脱氨酶活性的影响[J]. 郑州大学学报(医学版), 2011, 46(2): 248-251.

[32]

Lu Shan, Zhou Shuai, Chen Juwu, et al. Quercetin nanoparticle ameliorates lipopolysaccharide-triggered renal inflammatory impairment by regulation of Sirt1/ NF-KB pathway[J]. Journal of Biomedical Nanotechnology, 2021, 17(2): 230-241.

[33]

张妍, 李瑶, 赵亚妮, 等. 芒果苷、山柰酚和栀子苷对高尿酸血症小鼠的作用[J]. 西北药学杂志, 2021, 36(2): 215-219.

[34]

Haidari F, Keshavarz SA, Mohammad Shahi M, et al. Effects of parsley(Petroselinum crispum) and its flavonol constituents, kaempferol and quercetin, on serum uric acid levels, biomarkers of oxidative stress and liver xanthine oxidoreductase a activity in Oxonate-induced hyperuricemic rats[J]. Iranian Journal of Pharmaceutical Research, 2011, 10(4): 811-819.

[35]

Alam M, Ali S, Ashraf GM, et al. Epigallocatechin 3-gallate: From green tea to cancer therapeutics[J]. Food Chemistry, 2022, 379: 132135.

[36]

田锋祥, 丁鹏, 周玲玲. 芒柄花素调控核因子-κB 信号通路缓解软骨细胞炎症损伤作用[J]. 医药导报, 2024, 43(11): 1728-1732.

[37]

Zhang Peng, Liu Naicheng, Xue Mingyang, et al. Anti-inflammatory and antioxidant properties of β-sitosterol in copper sulfate-induced inflammation in zebrafish(Danio rerio)[J]. Antioxidants, 2023, 12(2): 391.

[38]

Vo TK, Ta QTH, Chu QT, et al. Anti-hepatocellular-cancer activity exerted by β-sitosterol and β-sitosterol-glucoside from Indigofera zollingeriana miq[J]. Molecules, 2020, 25(13): 3021.

[39]

Kastenhüber ER, Lowe SW. Putting p53 in context[J]. Cell, 2017, 170(6): 1062-1078.

[40]

Zhou You, Zhao Mingcai, Pu Zheyan, et al. Relationship between oxidative stress and inflammation in hyperuricemia: Analysis based on asymptomatic young patients with primary hyperuricemia[J]. Medicine, 2018, 97(49): e13108.

[41]

Hotamisligil G. Mechanisms of TNF-α-induced insulin resistance[J]. Experimental and Clinical Endocrinology & Diabetes, 1999, 107(2): 119-125.

[42]

Song Li, Xu Ruyue, Cai Wenpeng, et al. IL-6 upregulates the expression of IL-6R through the JAK2/ STAT3 signalling pathway to promote progression of hepatocellular carcinoma[J]. Scandinavian Journal of Immunology, 2023, 98(1): e13271.

[43]

Chinetti G, Fruchart JC, Staels B. Peroxisome proliferator-activated receptors(PPARs): Nuclear receptors with functions in the vascular wall[J]. Zeitschrift für Kardiologie, 2001, 90(3): 125-132.

[44]

Touyz RM, Schiffrin EL. Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications[J]. Vascular Pharmacology, 2006, 45(1): 19-28.

[45]

Julien O, Wells JA. Caspases and their substrates[J]. Cell Death & Differentiation, 2017, 24(8): 1380-1389.

[46]

Dai Yaxin, Lee CH. Transport mechanism and structural pharmacology of human urate transporter URAT1[J]. Cell Research, 2024, 34(11): 776-787.

[47]

Speisky H, Arias-Santé MF, Fuentes J. Oxidation of quercetin and kaempferol markedly amplifies their antioxidant, cytoprotective, and anti-inflammatory properties[J]. Antioxidants, 2023, 12(1): 155.

[48]

Guo Huizhi, Chen Xiaojun, Li Jinglan, et al. β-Sitosterol inhibits osteoclast activity and reduces ovariectomy-induced bone loss by regulating the cAMP and NF-κB signaling pathways[J]. Cellular Signalling, 2025, 130: 111672.

[49]

Huang Di, Wang Chuanyuan, Duan Yingjie, et al. Targeting Oct2 and P53: Formononetin prevents cisplatin-induced acute kidney injury[J]. Toxicology and Applied Pharmacology, 2017, 326: 15-24.

[50]

Libby P. The changing landscape of atherosclerosis[J]. Nature, 2021, 592(7855): 524-533.

[51]

Chen Xiaoxia, Wu Junlin, Fu Xiong, et al. Fructus Mori polysaccharide alleviates diabetic symptoms by regulating intestinal microbiota and intestinal barrier against TLR4/ NF-κB pathway[J]. International Journal of Biological Macromolecules, 2023, 249: 126038.

[52]

Balakumar P, Alqahtani A, Khan NA, et al. Mechanistic insights into hyperuricemia-associated renal abnormalities with special emphasis on epithelial-to-mesenchymal transition: Pathologic implications and putative pharmacologic targets[J]. Pharmacological Research, 2020, 161: 105209.

[53]

Wu Xiaqing, Zhang Dandan, Wang Yanni, et al. AGE/ RAGE in diabetic kidney disease and ageing kidney[J]. Free Radical Biology and Medicine, 2021, 171: 260-271.

基金资助

齐鲁工业大学(山东省科学院)科教产融合试点工程重大创新类项目(2024ZDZX03)

山东省技术创新引导计划(中央引导地方科技发展资金)项目(YDZX2024015)

山东省重点研发计划项目(2023TZXD003)

AI Summary AI Mindmap
PDF (19496KB)

0

访问

0

被引

详细

导航
相关文章

AI思维导图

/

〈 〉